You are here: Welcome » Stephanie Carlin

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Both sides next revision
stephanie_carlin [2022/05/01 20:36]
liam 		stephanie_carlin [2022/05/01 20:55] (current)
liam [Funding]
Line 4: Line 4:
  
 **Stephanie Carlin** is a Canadian clinical pharmacist based in [[Canada:ontario:Hamilton]], [[canada:Ontario]]. **Stephanie Carlin** is a Canadian clinical pharmacist based in [[Canada:ontario:Hamilton]], [[canada:Ontario]].
 +
 +===== Education =====
 +
 +==== University of Toronto ====
 +
 +Carlin attended the [[University of Toronto]] from 2006-2010 where she received a Bachelor of Science in Pharmacy.((//Stephanie Carlin - Education.// LinkedIn. Retrieved May 1, 2022, from https://www.linkedin.com/in/stephanie-carlin-6a471b13a/details/education/))
 +
 +Carlin recently finished an advanced practice pharmacy residency in [[thrombosis]] at [[Sunnybrook Health Sciences Centre]] through the [[University of Toronto]].((Carlin, S., Geerts, W., & Khosravani, H. (2021). //The clot thickens—enhanced integration of stroke and thrombosis training.// Journal of Thrombosis and Thrombolysis, 53(1), 17–19. https://doi.org/10.1007/s11239-021-02502-7))
  
 ===== Career and Affiliations ===== ===== Career and Affiliations =====
Line 9: Line 17:
 ==== Hamilton Health Sciences ==== ==== Hamilton Health Sciences ====
  
-Carlin is a clinical pharmacist at [[Hamilton Health Sciences]].+Carlin was a critical care pharmacist, and now a thrombosis pharmacist, at [[Hamilton Health Sciences]].((//Stephanie Carlin · Pharmacist · Hamilton Health Sciences.// OpenGovCA. Retrieved May 1, 2022, from https://web.archive.org/web/20220501183726/https://opengovca.com/ontario-employee/stephanie-carlin))
  
 ==== Ontario COVID-19 Science Advisory Table ==== ==== Ontario COVID-19 Science Advisory Table ====
  
 Carlin is a member of the Drugs & Biologics Clinical Practice Guidelines Working Group of the [[Ontario COVID-19 Science Advisory Table]].((//About Us.// Ontario COVID-19 Science Advisory Table. Retrieved April 28, 2022, from https://covid19-sciencetable.ca/about/)) Carlin is a member of the Drugs & Biologics Clinical Practice Guidelines Working Group of the [[Ontario COVID-19 Science Advisory Table]].((//About Us.// Ontario COVID-19 Science Advisory Table. Retrieved April 28, 2022, from https://covid19-sciencetable.ca/about/))
 +
 +===== Research =====
 +
 +Her research interests include optimization of antithrombotic use in clinical practice.
 +
 +==== Funding ====
 +
 +Carlin received funding from [[pharmaceutical_companies:Sanofi]] for her advanced
 +practice thrombosis residency program.((Carlin, S. (2021, February 10). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20220501184628/https://covid19-sciencetable.ca/wp-content/uploads/2021/02/Declaration-of-Interest_Drugs-and-Biologics-Clinical-Practice-Guidelines-Working-Group_Stephanie-Carlin-1.pdf))
 +
 +She also received joint payment from [[pharmaceutical_companies:Bristol-Myers Squibb]] and [[pharmaceutical_companies:Pfizer]] for an "educational presentation to health professionals on atrial fibrillation.((Carlin, S., & Eikelboom, J. (2022). //Advances in anticoagulation: patients with bioprosthetic heart valves.// Cardiovascular Research, 118(3), e26–e28. https://doi.org/10.1093/cvr/cvab360))
Back to top